Schünemann, Holger J; Mustafa, Reem A; Brozek, Jan; Santesso, Nancy; Bossuyt, Patrick M; Steingart, Karen R; Leeflang, Mariska; Lange, Stefan; Trenti, Tommaso; Langendam, Miranda; Scholten, Rob; Hooft, Lotty; Murad, Mohammad Hassan; Jaeschke, Roman; Rutjes, Anne; Singh, Jasvinder; Helfand, Mark; Glasziou, Paul; Rodriguez, Ingrid Arévalo; Akl, Elie A; ... (2019). GRADE Guidelines: 22. The GRADE approach for tests and strategies - from test accuracy to patient important outcomes and recommendations. Journal of clinical epidemiology, 111, pp. 69-82. Elsevier 10.1016/j.jclinepi.2019.02.003
Text
Schünemann JClinEidemiol 2019.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) |
||
|
Text
Schünemann JClinEidemiol 2019.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (1MB) | Preview |
OBJECTIVES
This article describes GRADE's framework of moving from test accuracy to patient or population important outcomes. We focus on the common scenario when studies directly evaluating the effect of diagnostic and other tests or strategies on health outcomes are not available or are not providing the best available evidence.
STUDY DESIGN AND SETTING
Using practical examples, we explored how guideline developers and other decision makers can use information from test accuracy to develop a recommendation by linking evidence that addresses downstream consequences. Guideline panels should develop an analytic framework that summarizes the actions that follow from applying a test, and the consequences.
RESULTS
We describe GRADE's current thinking about the overall certainty of the evidence (also known as quality of the evidence or confidence in the estimates) arising from consideration of the often complex pathways that involve multiple tests and management options. Each link in the evidence can - and often does - lower the overall certainty of the evidence required to formulate recommendations and make decisions about tests. The frequency with which an outcome occurs and its importance will influence whether or not a particular step in the linked evidence is critical to decision-making.
CONCLUSIONS
Overall certainty may be expressed by the weakest critical step in the linked evidence. The linked approach to addressing optimal testing will often require the use of decision analytic approaches. We present an example that involves decision modeling in a GRADE Evidence to Decision framework for cervical cancer screening. However, since resources and time of guideline developers may be limited, we describe alternative, pragmatic strategies for developing recommendations addressing test use.
Item Type: |
Journal Article (Review Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) 04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR) 04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM) |
UniBE Contributor: |
Rutjes, Anne |
Subjects: |
600 Technology > 610 Medicine & health 300 Social sciences, sociology & anthropology > 360 Social problems & social services |
ISSN: |
0895-4356 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Andrea Flükiger-Flückiger |
Date Deposited: |
05 Mar 2019 17:45 |
Last Modified: |
20 Feb 2024 14:16 |
Publisher DOI: |
10.1016/j.jclinepi.2019.02.003 |
PubMed ID: |
30738926 |
BORIS DOI: |
10.7892/boris.126630 |
URI: |
https://boris.unibe.ch/id/eprint/126630 |